Anatolian Journal of Cardiology最新文献

{"title":"Severe Diarrhea After Atrial Fibrillation Ablation and The Role of Vagal Plexus: A Case Series.","authors":"Uğur Nadir Karakulak, Cem Çöteli, Hikmet Yorgun, Kudret Aytemir","doi":"10.14744/AnatolJCardiol.2025.4722","DOIUrl":"10.14744/AnatolJCardiol.2025.4722","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143063310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Similar to the Original: Accessory Mitral Valve.","authors":"Uğur Nadir Karakulak","doi":"10.14744/AnatolJCardiol.2025.4328","DOIUrl":"10.14744/AnatolJCardiol.2025.4328","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143063314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adult-Onset Still's Disease: A Rare Cause of Acute Severe Mitral Regurgitation.","authors":"Ezgi Çamlı Babayiğit, Emre Şener, Erdi Babayiğit","doi":"10.14744/AnatolJCardiol.2025.4984","DOIUrl":"10.14744/AnatolJCardiol.2025.4984","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143063291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter Aortic Valve-in-Valve Implantation with Newer Generation Evolut Valve by Size of Failed Bioprosthesis.","authors":"Yoshiyuki Yamashita, Massimo Baudo, Serge Sicouri, Roberto Rodriguez, Eric M Gnall, Paul M Coady, Scott M Goldman, William A Gray, Basel Ramlawi","doi":"10.14744/AnatolJCardiol.2024.4633","DOIUrl":"10.14744/AnatolJCardiol.2024.4633","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the clinical outcomes of valve-in-valve transcatheter aortic valve replacement (ViV TAVR) with newer-generation self-expanding Evolut valves according to the size of the failed surgical bioprosthesis.</p><p><strong>Methods: </strong>This single-center retrospective study evaluated consecutive patients undergoing ViV TAVR with the Evolut Pro/Pro+/Fx between 2018 and 2022. These patients were compared based on the true internal diameter (ID) of the failed bioprosthesis, specifically ≤19 mm (small group) vs. >19 mm (large group). The primary endpoint was a composite of all-cause mortality, stroke, myocardial infarction, and bioprosthetic valve failure. A Cox regression hazard model adjusted for covariates using propensity scores was used to assess the effect of the true ID on clinical outcomes.</p><p><strong>Results: </strong>A total of 91 patients (small group, n = 35; large group, n = 56) were identified, and the median age of the entire cohort was 78 years. Patients in the small group were more likely to be female and have a small body surface area. The incidence of post-procedural mean gradient ≥20 mm Hg (40% vs. 8.9%, P = .001) and moderate/severe prosthesis-patient mismatch (63% vs. 38%, P < .001) was significantly higher in the small group. During a median follow-up period of 25 (range: 1.0-66) months, all-cause mortality showed no significant difference between the groups (adjusted P = .104); however, the rate of the primary composite outcome was significantly higher in the small group (adjusted hazard ratio 3.72, 95% CI 1.48; 9.37).</p><p><strong>Conclusion: </strong>Valve-in-valve transcatheter aortic valve replacement for small bioprostheses was associated with worse early and midterm outcomes compared with those for large bioprostheses.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143623247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of 1-Year Clinical Outcomes Between Ticagrelor Versus Clopidogrel in Type 2 Diabetes Patients After Implantation of Small Diameter Stents.","authors":"Alaa S Algazzar, Raghad M Aljondi, Eilaf Majdi Metwalli, Ghazal Y Dhaher, Hanan H Mushaeb, Renad H Aljadani, Rahaf S Balahmar, Awatif Hafiz, Mohamed A Qutub","doi":"10.14744/AnatolJCardiol.2024.4603","DOIUrl":"10.14744/AnatolJCardiol.2024.4603","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) patients with small-diameter stents (SDS), that are equal to or less than 2.5 mm in diameter, face increased risks of restenosis and complications. This study aimed to evaluate the 1-year follow-up to assess the rate of major adverse cardiac events (MACE) and bleeding risk between ticagrelor and clopidogrel in T2DM patients after SDS implantation.</p><p><strong>Methods: </strong>The study was a single-center, prospective controlled registry trial, which included 332 T2DM patients who underwent percutaneous coronary intervention with SDS implantation. Follow-up was conducted for 1 year.</p><p><strong>Results: </strong>Following propensity score matching, the 1-year analysis revealed no significant difference in the risk of the composite MACE between clopidogrel and ticagrelor groups (P = .295). Male gender, history of ischemic heart disease, ejection fraction (EF), coronary lesion type, and chronic kidney disease (CKD) were identified as potential predictors for the composite endpoint. In a subanalysis of CKD patients, the 12-month rates of composites of cardiac death (CD), myocardial infarction (MI), stroke, and target vessel revascularization (TVR) were lower in the ticagrelor group than in the clopidogrel group (P = .024). However, the ticagrelor group was associated with a higher rate of bleeding compared to the clopidogrel group (20% vs. 9%) (P = .041).</p><p><strong>Conclusion: </strong>Our study demonstrated that ticagrelor did not show improvement in the composite of CD, MI, stroke, TVR, or the risk of bleeding events defined by the BARC criteria in patients with T2DM and SDS compared with clopidogrel emphasizing the importance of individualized treatment decisions based on patient characteristics. However, the results may not be representative of the entire population.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11793804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ventricular Septal Rupture as a Complication of Acute Myocardial Infarction: Clinical Characteristics and Prognostic Comparison of Different Treatment Methods.","authors":"Zhongchun He, Zhaofei Wang, Bo Dong, Qiuxiang Long","doi":"10.14744/AnatolJCardiol.2024.4674","DOIUrl":"10.14744/AnatolJCardiol.2024.4674","url":null,"abstract":"<p><strong>Background: </strong>This research aimed to investigate the clinical features exhibited by individuals diagnosed with acute myocardial infarction (AMI) complicated by ventricular septal rupture (VSR) and to compare the prognostic outcomes of different treatment modalities.</p><p><strong>Methods: </strong>A retrospective study on a cohort of 200 patients who were diagnosed with AMI complicated by VSR at a specialized medical facility from 2018 to 2023 was conducted. The patients were categorized into 3 different treatment groups: group A received medical management, group B underwent surgical repair, and group C underwent percutaneous device closure. Our primary objective was to assess the overall mortality rate within 1 year, while secondary objectives included evaluating in-hospital mortality, mortality within 30 days, and occurrence of major adverse cardiovascular events within 1 year.</p><p><strong>Results: </strong>Group A showed the highest in-hospital mortality rate of 37.3%. The rate for group B was only 20.6%, while group C exhibited the lowest rate of 17.4%. A similar tendency was observed for the 30-day and 1-year mortality rates. The 30-day mortality rate for group A, group B, and group C was 56.9%, 20.6%, and 22.1%, respectively. The 1-year mortality rate for group A, group B, and group C was as follows: 31.4%, 28.6%, and 25.6%. In addition, the incidence of major adverse cardiovascular events at 1 year was highest in group A (56.9%), followed by group B (28.6%) and group C (32.6%).</p><p><strong>Conclusion: </strong>Both surgical repair and percutaneous device closure were associated with significantly better survival outcomes compared to medical management alone in patients with AMI complicated by VSR.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143623248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to Letter to the Editor: \"Is Right Ventricle- to-Left Ventricle Diameter Ratio, A Static Parameter Measured by Computed Tomography Pulmonary Angiography, An Effective Index of Right Ventricular Function?''.","authors":"Serhat Erol, Aslıhan Gürün Kaya, Fatma Arslan, Sümeyye Ayöz, Ayşegül Gürsoy Çoruh, Melahat Kul, Evren Özçınar, Aydın Çiledağ, Zeynep Pınar Önen, Akın Kaya, Özlem Özdemir Kumbasar, Stavros V Konstantinides","doi":"10.14744/AnatolJCardiol.2024.4938","DOIUrl":"10.14744/AnatolJCardiol.2024.4938","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of Thrombomodulin Polymorphism -33G>A on Acute Myocardial Infarction Risk and Circulating Inflammatory Markers.","authors":"Sounira Mehri, Raja Chaaba, Josef Finsterer, Wided Khamlaoui, Sonia Hammami, Mohamed Hammami","doi":"10.14744/AnatolJCardiol.2024.4534","DOIUrl":"10.14744/AnatolJCardiol.2024.4534","url":null,"abstract":"<p><strong>Background: </strong>There is increasing evidence that thrombomodulin (THBD) polymorphisms, along with inflammatory markers [i.e., C-reactive protein (CRP), fibrinogen, albumin], may increase the risk of acute myocardial infarction (AMI). The aim of the study was to investigate the role of the THBD -33G>A polymorphism (rs1042579) as a marker of AMI risk and to correlate it with serum levels of inflammatory markers.</p><p><strong>Methods: </strong>Case-control study of 277 AMI patients and 329 healthy controls. A binary logistic regression analysis was performed to evaluate the association between the parameters studied and AMI risk.</p><p><strong>Results: </strong>The frequencies of genotypes AA, GA, and GG of the THBD -33G>A polymorphism were 31.4%, 45.5%, and 23.1% in patients and 21.6%, 44.1%, and 34.3% in controls. A significant association was found between the AA genotype of the THBD -33G>A polymorphism (AA: OR = 2.011, 95% CI 1.561-3.074, P < .001) or A allele (A: OR = 1.725, 95% CI 1.493-2.510, P < .001) and AMI risk. A backward stepwise logistic regression method combining AMI status as the dependent variable and conventional risk factors (age, smoking, arterial hypertension (HTA), diabetes, dyslipidemia, CRP, albumin, fibrinogen, serum angiotensin converting enzyme (ACE) activity, serum malondialdehyde, conjugated dienes, glutathione peroxidase, cardiac troponin-I (cTnI) and THBD AA genotype) as independent variables showed that the most predictive risk factors for AMI were smoking, HTA, albumin, fibrinogen, CRP, ACE activity, cTnI, and the THBD AA-genotype with odds ratios of 2.942, 2.203, 2.352, 1.323, 1.652, 1.014, 2.105, and 3.781 respectively. The AA genotype was associated with increased diastolic blood pressure, CRP, ACE activity, and albumin levels.</p><p><strong>Conclusions: </strong>The study shows that the THBD -33G>A polymorphism should be included in the stratification of AMI risk.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11793801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Echocardiographic Study of a Rare Cause of Mitral Regurgitation: Hypoplastic Posterior Mitral Valve Leaflet.","authors":"Ahmet Karaduman, Cemalettin Yılmaz, İsmail Balaban, Mehmet Aytürk, Münevver Sarı, Zübeyde Bayram, Alev Kılıçgedik, Gökhan Kahveci","doi":"10.14744/AnatolJCardiol.2024.4710","DOIUrl":"10.14744/AnatolJCardiol.2024.4710","url":null,"abstract":"<p><strong>Background: </strong>The precise etiology of hypoplasia of the posterior mitral valve leaflet (PMVL) remains incompletely elucidated; however, it has been hypothesized to stem from genetic mutations occurring during fetal development. Herein, we present the anatomical characteristics of the mitral valve and associated cardiac pathologies in patients with hypoplastic PMVL.</p><p><strong>Methods: </strong>This single-center retrospective study involved patients who presented between 2015 and 2021 at a tertiary healthcare facility. Among the cohort, 44 individuals had hypoplastic PMVL and were divided into 2 groups: those with severe mitral regurgitation (MR) and those with non-severe MR.</p><p><strong>Results: </strong>Among the patients, 11 (25%) had severe MR. The median lengths for the PMVL was 5 mm (5-6). Moreover, 10 patients had concomitant muscular formation. We found that 13 patients had bicuspid aortic valve (BAV), while the second most common concomitant cardiac congenital pathology was secundum atrial septal defect (ASD) in 7 patients. The anterior mitral leaflet (AML) length (P = .007), AML prolapse (P < .001), and A2P2 distance (P = .008) were higher in the group with severe MR. In addition, muscular formation was more common in patients with hypoplastic PMVL with severe MR (P < .001).</p><p><strong>Conclusion: </strong>Hypoplastic PMVL is a rare but significant anomaly that causes MR. While it can coexist with numerous congenital conditions, the most frequent associations include BAV and, secondly, ASD. Severe MR is particularly observed in cases accompanied by dilated mitral annulus, AML prolapse, and muscular formation.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Right Ventricle-to-Left Ventricle Diameter Ratio, A Static Parameter Measured by Computed Tomography Pulmonary Angiography, An Effective Index of Right Ventricular Function?","authors":"Abdulrahman Naser","doi":"10.14744/AnatolJCardiol.2024.4937","DOIUrl":"10.14744/AnatolJCardiol.2024.4937","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}